Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_54d575dca64fac4e44b9e665ccfa7cbf |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-32023 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2750-12022 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-00042 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-00034 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-32022 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-585 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2750-12023 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6901 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5184 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-555 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-69 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-51 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-555 |
filingDate |
2016-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2936cb45fb82ecd574b8803f760e2f52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_70e33102e10f28a9859452096618f234 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_87b8096fc53aaf0ccb532e66db8fca1d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a101370a54ad09193dd4a26b77cc1bfd |
publicationDate |
2019-01-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2019015525-A1 |
titleOfInvention |
Anticancer drug-containing plant virus particles |
abstract |
Anticancer virus particles are described. Anticancer virus particles are filamentous or rod-shaped plant virus particle containing an anticancer agent within the interior of the virus particle. The anticancer agent can be attached either covalently or non-covalently within the interior of the virus particle. A therapeutically effective amount of an anticancer virus particle can be administered to a subject identified as having cancer to provide a method of cancer treatment. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10723748-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11572379-B2 |
priorityDate |
2015-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |